US Patent 11406600 Anhydrous dasatinib-containing preparation
Patent 11406600 was granted and assigned to Sawai Pharmaceutical on August, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 20, 2020
0
Date of Patent
August 9, 2022
0
Patent Applicant
Patent Application Number
16879408
0
Patent Inventor Names
Hiroaki Kikuoka
0
Hiroyuki Yamamoto
0
Michinori Oikawa
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11406600 Anhydrous dasatinib-containing preparation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.